Key payer types
| Payer type | Description | Country |
| Private insurance markets | Free market environment with competing private insurance | USA, Switzerland |
| Therapeutic reference markets | Relative therapeutic effectiveness index (demonstrated meaningful benefits over comparator) | Germany, France |
| Cost-effectiveness markets | Rigid modelling and value thresholds | England |
| Budget impact markets | Cost to system to adopt new therapy | Italy, Spain |